Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Bioiberica
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.
Product Name : Condrovet
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
September 06, 2020
Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Bioiberica
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 03, 2019
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : T&T Family Health Clinic and Surgery | Temasek Polytechnic School of Applied Science, Singapore
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 16, 2018
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : T&T Family Health Clinic and Surgery | Temasek Polytechnic School of Applied Science, Singapore
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 13, 2016
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 13, 2013
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 29, 2010
Lead Product(s) : Glucosamine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable